{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:52:42Z","timestamp":1788306762190,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is an idiopathic, chronic, relapsing inflammatory bowel disease (IBD), characterized by chronic inflammation of the gastrointestinal tract. The pathophysiology of UC is complicated and involves several factors including immune, genetic, and environmental factors. Recently, a huge amount of research has concentrated on the role of interleukins including interleukin-6 (IL-6) in its pathophysiology. Thus, this study aims to examine the colo-protective and immunomodulatory effect of Tocilizumab (TCZ) in an experimental model of dextran sulfate sodium (DSS) induced UC. In the current study, we analyzed the inflammatory, immunomodulatory, apoptotic, autophagy, and endoplasmic reticulum (ER) stress markers and other clinical features including stool consistency, rectal bleeding, and edema markers in rats. Our results showed that induction of colitis caused bloody diarrhea and increased IL-6 levels. Treatment with TCZ significantly ameliorated DSS-induced injury via decreasing inflammatory markers of colon injury (IL-6), signal transducer and activator of transcription-3 (STAT-3), and C-reactive protein (CRP). Furthermore, TCZ attenuated the apoptotic marker (caspase-3), and down-regulated endoplasmic reticulum stress sensor proteins (inositol- requiring transmembrane kinase endonuclease-1 (IRE-1) and activated transcription factor-6 (ATF-6)) and autophagy proteins (autophagy-related 16-like protein 1 (ATG16L1) and nucleotide-binding oligomerization domain-containing protein-2 (NOD2)), as compared to DSS group. Altogether, the current data suggest TCZ to be a promising protective therapy against UC.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10787-024-01527-7","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T13:03:10Z","timestamp":1723467790000},"page":"3881-3898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling"],"prefix":"10.1007","volume":"32","author":[{"given":"Omnia A.","family":"Younes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"Elsherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M. F.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-8280","authenticated-orcid":false,"given":"Samar S.","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"1527_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.taap.2018.07.014","volume":"356","author":"AE Abdel-Maged","year":"2018","unstructured":"Abdel-Maged AE et al (2018) Comparative study of anti-VEGF Ranibizumab and interleukin-6 receptor antagonist Tocilizumab in adjuvant-induced arthritis. Toxicol Appl Pharmacol 356:65","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"1527_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/00365521.2018.1447597","volume":"53","author":"B Ahluwalia","year":"2018","unstructured":"Ahluwalia B et al (2018) Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 53(4):379","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"1527_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2174\/1389450117666160527142719","volume":"19","author":"M Allocca","year":"2018","unstructured":"Allocca M et al (2018) Biologic therapies in ulcerative colitis: prime inter pares? Curr Drug Targ 19(7):748","journal-title":"Curr Drug Targ"},{"issue":"8","key":"1527_CR5","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3390\/nano11082035","volume":"11","author":"JC Antunes","year":"2021","unstructured":"Antunes JC et al (2021) Drug targeting of Inflammatory bowel diseases by biomolecules. Nanomaterials (basel) 11(8):2035","journal-title":"Nanomaterials (basel)"},{"issue":"2","key":"1527_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1053\/j.gastro.2012.11.035","volume":"144","author":"C Becker","year":"2013","unstructured":"Becker C et al (2013) Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144(2):283","journal-title":"Gastroenterology"},{"issue":"6","key":"1527_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","volume":"3","author":"JM Benson","year":"2011","unstructured":"Benson JM et al (2011) Discovery and mechanism of ustekinumab. Mabs 3(6):535","journal-title":"Mabs"},{"issue":"2","key":"1527_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jdds.2015.03.003","volume":"19","author":"K Beroukhim","year":"2015","unstructured":"Beroukhim K et al (2015) A case report of heart failure after therapy with ustekinumab. J Dermatol Dermatol Surg 19(2):117","journal-title":"J Dermatol Dermatol Surg"},{"issue":"4","key":"1527_CR9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/MIB.0000000000000660","volume":"22","author":"SS Cao","year":"2016","unstructured":"Cao SS (2016) Epithelial ER stress in Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis 22(4):984","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"1527_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220178","volume":"14","author":"B Castagn\u00e9","year":"2019","unstructured":"Castagn\u00e9 B et al (2019) Cardiovascular safety of tocilizumab: a systematic review and network meta-analysis. PLoS ONE 14(8):e0220178","journal-title":"PLoS ONE"},{"issue":"11","key":"1527_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/ecco-jcc\/jjab070","volume":"15","author":"M Chaparro","year":"2021","unstructured":"Chaparro M et al (2021) Effectiveness and safety of Ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry. J Crohns Colitis 15(11):1846","journal-title":"J Crohns Colitis"},{"issue":"15","key":"1527_CR12","first-page":"11","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing B et al (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104(15):11\u201315","journal-title":"Curr Protoc Immunol"},{"issue":"6","key":"1527_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH et al (2020) Translating IL-6 biology into effective treatments. Nat Rev Rheumatol 16(6):335","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1527_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050407","volume":"7","author":"I Crespo","year":"2012","unstructured":"Crespo I et al (2012) Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis. PLoS ONE 7(11):e50407","journal-title":"PLoS ONE"},{"issue":"4","key":"1527_CR15","first-page":"483","volume":"6","author":"KM Das","year":"2000","unstructured":"Das KM, Farag SA (2000) Current medical therapy of inflammatory bowel disease. World J Gastroenterol 6(4):483","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1527_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1756283X09102329","volume":"2","author":"S Garud","year":"2009","unstructured":"Garud S, Peppercorn MA (2009) Ulcerative colitis: current treatment strategies and prospects. Therap Adv Gastroenterol 2(2):99\u2013108","journal-title":"Therap Adv Gastroenterol"},{"issue":"7","key":"1527_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1023\/A:1026620322859","volume":"44","author":"E Gaudio","year":"1999","unstructured":"Gaudio E et al (1999) Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44(7):1458","journal-title":"Dig Dis Sci"},{"key":"1527_CR18","doi-asserted-by":"publisher","first-page":"7247238","DOI":"10.1155\/2019\/7247238","volume":"2019","author":"Q Guan","year":"2019","unstructured":"Guan Q (2019) A comprehensive review and Update on the pathogenesis of Inflammatory bowel disease. J Immunol Res 2019:7247238","journal-title":"J Immunol Res"},{"issue":"10","key":"1527_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2169\/internalmedicine.5215-20","volume":"60","author":"Y Hanioka","year":"2021","unstructured":"Hanioka Y et al (2021) Exacerbation of ulcerative colitis with Tocilizumab: a report of two cases, one with Takayasu arteritis and the other with relapsing polychondritis. Intern Med 60(10):1615\u20131620","journal-title":"Intern Med"},{"issue":"11","key":"1527_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","volume":"47","author":"M Hashizume","year":"2008","unstructured":"Hashizume M et al (2008) IL-6 trans-signaling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (oxford) 47(11):1635","journal-title":"Rheumatology (oxford)"},{"issue":"1","key":"1527_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/CMR.15.1.79-94.2002","volume":"15","author":"BA Hendrickson","year":"2002","unstructured":"Hendrickson BA et al (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1527_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MOG.0000000000000144","volume":"31","author":"S Hosomi","year":"2015","unstructured":"Hosomi S et al (2015) Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 31(1):81","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"1527_CR23","first-page":"2490","volume":"8","author":"Y Huang","year":"2016","unstructured":"Huang Y, Chen Z (2016) Inflammatory bowel disease related innate immunity and adaptive immunity. Am J Transl Res 8(6):2490\u20132497","journal-title":"Am J Transl Res"},{"issue":"11","key":"1527_CR24","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3748\/wjg.v23.i11.1944","volume":"23","author":"T Iida","year":"2017","unstructured":"Iida T et al (2017) Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 23(11):1944","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1527_CR25","first-page":"328","volume":"44","author":"A Kaistha","year":"2014","unstructured":"Kaistha A, Levine J (2014) Inflammatory bowel disease: the classic gastrointestinal autoimmune disease. Curr ProblPediatrAdolesc Health Care 44(11):328","journal-title":"Curr ProblPediatrAdolesc Health Care"},{"issue":"8","key":"1527_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/ijms19082299","volume":"19","author":"MM Kasembeli","year":"2018","unstructured":"Kasembeli MM et al (2018) Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment. Int J Mol Sci 19(8):229","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1527_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.smim.2009.01.001","volume":"21","author":"A Kaser","year":"2009","unstructured":"Kaser A, Blumberg RS (2009) Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease. Semin Immunol 21(3):156","journal-title":"Semin Immunol"},{"issue":"1","key":"1527_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12950-020-00246-4","volume":"17","author":"A Kaur","year":"2020","unstructured":"Kaur A, Goggolidou P (2020) Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies. J Inflamm 17(1):15","journal-title":"J Inflamm"},{"issue":"1","key":"1527_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jcm9010094","volume":"9","author":"M Kayal","year":"2019","unstructured":"Kayal M, Shah S (2019) Ulcerative colitis: current and emerging treatment strategies. J Clin Med 9(1):94","journal-title":"J Clin Med"},{"key":"1527_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1916","volume":"8","author":"T Kishimoto","year":"2006","unstructured":"Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8:1\u20136","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1527_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038801","volume":"7","author":"MJ Lee","year":"2012","unstructured":"Lee MJ et al (2012) Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS ONE 7(9):e38801","journal-title":"PLoS ONE"},{"key":"1527_CR33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ebiom.2019.10.002","volume":"48","author":"M Lleal","year":"2019","unstructured":"Lleal M et al (2019) A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis. EBioMedicine 48:630","journal-title":"EBioMedicine"},{"key":"1527_CR34","first-page":"1341","volume":"7","author":"D Low","year":"2013","unstructured":"Low D et al (2013) Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther 7:1341","journal-title":"Drug Des Devel Ther"},{"key":"1527_CR36","volume-title":"Biological therapy for inflammatory bowel disease","author":"P Martina","year":"2019","unstructured":"Martina P, Ana U (2019) The role of TNF in the pathogenesis of inflammatory bowel disease. In: Raquel Franco L, Tristan Rijeka T (eds) Biological therapy for inflammatory bowel disease. IntechOpen"},{"issue":"4","key":"1527_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4161\/self.1.4.13560","volume":"1","author":"J Matricon","year":"2010","unstructured":"Matricon J et al (2010) Immunopathogenesis of inflammatory bowel disease. Self Nonself 1(4):299","journal-title":"Self Nonself"},{"key":"1527_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/718314","author":"A Matuszyk","year":"2015","unstructured":"Matuszyk A et al (2015) The Influence of ghrelin on the development of dextran sodium sulfate-induced colitis in rats. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/718314","journal-title":"Biomed Res Int"},{"key":"1527_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/OARRR.S17118","volume":"3","author":"M Mihara","year":"2011","unstructured":"Mihara M et al (2011) Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis. Open Access Rheumatol 3:19","journal-title":"Open Access Rheumatol"},{"issue":"6a","key":"1527_CR40","first-page":"3749","volume":"27","author":"K Mitsuyama","year":"2007","unstructured":"Mitsuyama K et al (2007) Therapeutic strategies for targeting the IL-6\/STAT3 cytokine signaling pathway in inflammatory bowel disease. Anticancer Res 27(6a):3749","journal-title":"Anticancer Res"},{"issue":"9","key":"1527_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-250376","volume":"15","author":"E Morgenweck","year":"2022","unstructured":"Morgenweck E et al (2022) Heart failure associated with ustekinumab therapy for the treatment of Crohn\u2019s disease. BMJ Case Rep 15(9):e250376","journal-title":"BMJ Case Rep"},{"issue":"10","key":"1527_CR42","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/nu11102309","volume":"11","author":"MA Morsy","year":"2019","unstructured":"Morsy MA et al (2019) Protective effect of spirulina platensis extract against dextran-sulfate-sodium-induced ulcerative colitis in rats. Nutrients 11(10):2309","journal-title":"Nutrients"},{"issue":"11","key":"1527_CR43","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.3390\/ijms19113528","volume":"19","author":"M Narazaki","year":"2018","unstructured":"Narazaki M, Kishimoto T (2018) The two-faced Cytokine IL-6 in host defense and diseases. Int J Mol Sci 19(11):3528","journal-title":"Int J Mol Sci"},{"key":"1527_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/218493","author":"T Nunes","year":"2014","unstructured":"Nunes T et al (2014) Cell death and Inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/218493","journal-title":"Biomed Res Int"},{"issue":"6","key":"1527_CR45","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1476-4431.2008.00363.x","volume":"18","author":"MA O'Brien","year":"2008","unstructured":"O\u2019Brien MA, Kirby R (2008) Apoptosis: a review of proapoptotic and antiapoptotic pathways and dysregulation in disease. J Vet Emerg Crit Care (san Antonio) 18(6):572","journal-title":"J Vet Emerg Crit Care (san Antonio)"},{"issue":"4","key":"1527_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","volume":"49","author":"BS Pabla","year":"2020","unstructured":"Pabla BS, Schwartz DA (2020) Assessing severity of disease in patients with ulcerative colitis. Gastroenterol Clin North Am 49(4):671\u2013688","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"1527_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3748\/wjg.v20.i1.64","volume":"20","author":"J Pedersen","year":"2014","unstructured":"Pedersen J et al (2014) Inflammatory pathways of importance for management of inflammatory bowel disease. World J Gastroenterol 20(1):64","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1527_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14(3):141","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1527_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417","journal-title":"N Engl J Med"},{"issue":"4","key":"1527_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","volume":"18","author":"PK Randhawa","year":"2014","unstructured":"Randhawa PK et al (2014) A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 18(4):279","journal-title":"Korean J Physiol Pharmacol"},{"issue":"4","key":"1527_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/gut.51.4.529","volume":"51","author":"E Rijcken","year":"2002","unstructured":"Rijcken E et al (2002) ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease. Gut 51(4):529","journal-title":"Gut"},{"issue":"1","key":"1527_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1074-7613(04)00003-2","volume":"20","author":"S Rose-John","year":"2004","unstructured":"Rose-John S, Neurath MF (2004) IL-6 trans-signaling: the heat is on. Immunity 20(1):2\u20134","journal-title":"Immunity"},{"key":"1527_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0528","author":"RB Sartor","year":"2006","unstructured":"Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. https:\/\/doi.org\/10.1038\/ncpgasthep0528","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"46","key":"1527_CR54","doi-asserted-by":"publisher","first-page":"13020","DOI":"10.3748\/wjg.v21.i46.13020","volume":"21","author":"A Senol","year":"2015","unstructured":"Senol A et al (2015) Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats. World J Gastroenterol 21(46):13020","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1527_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"SS Seyedian","year":"2019","unstructured":"Seyedian SS et al (2019) A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12(2):113","journal-title":"J Med Life"},{"issue":"7","key":"1527_CR56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/ibd\/izaa258","volume":"27","author":"P Sinh","year":"2021","unstructured":"Sinh P, Cross R (2021) Cardiovascular risk assessment and impact of medications on cardiovascular disease in inflammatory bowel disease. Inflamm Bowel Dis 27(7):1107","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1527_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/rheumatology\/kem336","volume":"47","author":"Y Sote","year":"2007","unstructured":"Sote Y et al (2007) Complete heart block after infliximab therapy. Rheumatology 47(2):227","journal-title":"Rheumatology"},{"issue":"4","key":"1527_CR58","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40259-017-0231-8","volume":"31","author":"V Strand","year":"2017","unstructured":"Strand V et al (2017) Immunogenicity of biologics in chronic inflammatory diseases: a systematic review. BioDrugs 31(4):299","journal-title":"BioDrugs"},{"key":"1527_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7562123","author":"MCH Szeto","year":"2016","unstructured":"Szeto MCH et al (2016) Successful use of tocilizumab in a patient with coexisting rheumatoid arthritis and ulcerative colitis. Case Rep Immunol. https:\/\/doi.org\/10.1155\/2016\/7562123","journal-title":"Case Rep Immunol"},{"issue":"10","key":"1527_CR60","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T et al (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"1527_CR61","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1440-1746.1998.tb00766.x","volume":"13","author":"T Taniguchi","year":"1998","unstructured":"Taniguchi T et al (1998) Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats. J Gastroenterol Hepatol 13(9):945\u2013949","journal-title":"J Gastroenterol Hepatol"},{"key":"1527_CR62","doi-asserted-by":"publisher","first-page":"1603990","DOI":"10.3389\/phrs.2021.1603990","volume":"42","author":"P Tavakoli","year":"2021","unstructured":"Tavakoli P et al (2021) A review of inflammatory bowel disease: a model of microbial, immune and neuropsychological integration. Public Health Rev 42:1603990","journal-title":"Public Health Rev"},{"issue":"18","key":"1527_CR63","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/CM9.0000000000002792","volume":"136","author":"Y Tie","year":"2023","unstructured":"Tie Y et al (2023) Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease. Chin Med J (engl) 136(18):2143","journal-title":"Chin Med J (engl)"},{"key":"1527_CR64","first-page":"1","volume":"2","author":"A Toufaily","year":"2020","unstructured":"Toufaily A (2020) Severe cardiomyopathy induced by adalimumab administration for Crohn\u2019s disease. J Cardio Case Rep 2:1","journal-title":"J Cardio Case Rep"},{"issue":"43","key":"1527_CR65","doi-asserted-by":"publisher","first-page":"6843","DOI":"10.3748\/wjg.v11.i43.6843","volume":"11","author":"JK Triantafillidis","year":"2005","unstructured":"Triantafillidis JK et al (2005) Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 11(43):6843\u20136847","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1527_CR66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14712598.2016.1150997","volume":"16","author":"JL Turnier","year":"2016","unstructured":"Turnier JL, Brunner HI (2016) Tocilizumab for treating juvenile idiopathic arthritis. Expert Opin Biol Ther 16(4):559","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"1527_CR67","doi-asserted-by":"publisher","first-page":"G763","DOI":"10.1152\/ajpgi.00004.2013","volume":"305","author":"V Valatas","year":"2013","unstructured":"Valatas V et al (2013) The value of experimental models of colitis in predicting the efficacy of biological therapies for inflammatory bowel diseases. Am J PhysiolGastrointest Liver Physiol 305(11):G763","journal-title":"Am J PhysiolGastrointest Liver Physiol"},{"issue":"3","key":"1527_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000365309","volume":"1","author":"ZH Wang","year":"2014","unstructured":"Wang ZH, Fang JY (2014) Colorectal cancer in Inflammatory bowel disease: epidemiology, pathogenesis and surveillance. Gastrointest Tumors 1(3):146","journal-title":"Gastrointest Tumors"},{"issue":"4","key":"1527_CR69","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","volume":"44","author":"SW Wang","year":"2014","unstructured":"Wang SW, Sun YM (2014) The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer. Int J Oncol 44(4):1032","journal-title":"Int J Oncol"},{"issue":"29","key":"1527_CR72","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.3748\/wjg.v11.i29.4579","volume":"11","author":"XM Xu","year":"2005","unstructured":"Xu XM et al (2005) Effects of garlicin on apoptosis in rat model of colitis. World J Gastroenterol 11(29):4579","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1527_CR73","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/metabo12080676","volume":"12","author":"X Xu","year":"2022","unstructured":"Xu X et al (2022) \"Berberine ameliorates dextran sulfate sodium-induced ulcerative colitis and inhibits the secretion of gut lysozyme via promoting autophagy. Metabolites 12(8):676","journal-title":"Metabolites"},{"issue":"6","key":"1527_CR74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1759720X12455960","volume":"4","author":"S Yokota","year":"2012","unstructured":"Yokota S et al (2012) Efficacy, safety, and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis. Ther Adv Musculoskelet Dis 4(6):387","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"1527_CR75","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5152\/tjg.2019.18342","volume":"30","author":"W Yue","year":"2019","unstructured":"Yue W et al (2019) Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity. Turk J Gastroenterol 30(3):290","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"1527_CR76","first-page":"99","volume":"15","author":"J Zhu","year":"2023","unstructured":"Zhu J et al (2023) Tocilizumab attenuates acute lung injury in rats with sepsis by regulating S100A12\/NLRP3. Am J Transl Res 15(1):99","journal-title":"Am J Transl Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01527-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01527-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01527-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T12:04:53Z","timestamp":1731153893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01527-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1527"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01527-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}